624 related articles for article (PubMed ID: 30554299)
1. Molecular Identification and Antifungal Susceptibility of Clinical Isolates of Sporothrix schenckii Complex in Medellin, Colombia.
Flórez-Muñoz SV; Alzate JF; Mesa-Arango AC
Mycopathologia; 2019 Feb; 184(1):53-63. PubMed ID: 30554299
[TBL] [Abstract][Full Text] [Related]
2. Sporothrix schenckii complex in Iran: Molecular identification and antifungal susceptibility.
Mahmoudi S; Zaini F; Kordbacheh P; Safara M; Heidari M
Med Mycol; 2016 Aug; 54(6):593-9. PubMed ID: 26933207
[TBL] [Abstract][Full Text] [Related]
3. Canine sporotrichosis: polyphasic taxonomy and antifungal susceptibility profiles of Sporothrix species in an endemic area in Brazil.
Boechat JS; Pereira SA; de Sá Machado AC; Viana PG; Almeida-Paes R; Zancopé-Oliveira RM; Gremião IDF; de Oliveira MME
Braz J Microbiol; 2021 Mar; 52(1):135-143. PubMed ID: 32617836
[TBL] [Abstract][Full Text] [Related]
4. Feline sporotrichosis caused by Sporothrix schenckii sensu stricto in Southern Thailand: phenotypic characterization, molecular identification, and antifungal susceptibility.
Indoung S; Chanchayanon B; Chaisut M; Buapeth KO; Morteh R; Jantrakajorn S
Med Mycol; 2022 Sep; 60(9):. PubMed ID: 36130102
[TBL] [Abstract][Full Text] [Related]
5. Studies in Phylogeny, Development of Rapid IdentificationMethods, Antifungal Susceptibility, and Growth Rates of Clinical Strains of Sporothrix schenckii Complex in Japan.
Suzuki R; Yikelamu A; Tanaka R; Igawa K; Yokozeki H; Yaguchi T
Med Mycol J; 2016; 57(3):E47-57. PubMed ID: 27581775
[TBL] [Abstract][Full Text] [Related]
6. Molecular identification and susceptibility profile of Sporothrix schenckii sensu lato isolated in Argentina.
Córdoba S; Isla G; Szusz W; Vivot W; Hevia A; Davel G; Canteros CE
Mycoses; 2018 Jul; 61(7):441-448. PubMed ID: 29500853
[TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibilities and identification of species of the Sporothrix schenckii complex isolated in Brazil.
Ottonelli Stopiglia CD; Magagnin CM; Castrillón MR; Mendes SD; Heidrich D; Valente P; Scroferneker ML
Med Mycol; 2014 Jan; 52(1):56-64. PubMed ID: 23964828
[TBL] [Abstract][Full Text] [Related]
8. Antifungal susceptibilities of Sporothrix albicans, S. brasiliensis, and S. luriei of the S. schenckii complex identified in Brazil.
Oliveira DC; Lopes PG; Spader TB; Mahl CD; Tronco-Alves GR; Lara VM; Santurio JM; Alves SH
J Clin Microbiol; 2011 Aug; 49(8):3047-9. PubMed ID: 21653757
[TBL] [Abstract][Full Text] [Related]
9. Refractory sporotrichosis due to Sporothrix brasiliensis in humans appears to be unrelated to in vivo resistance.
Almeida-Paes R; Oliveira MME; Freitas DFS; Valle ACFD; Gutierrez-Galhardo MC; Zancopé-Oliveira RM
Med Mycol; 2017 Jul; 55(5):507-517. PubMed ID: 27771622
[TBL] [Abstract][Full Text] [Related]
10. Potential use of Nikkomycin Z as an anti- Sporothrix spp. drug.
Poester VR; Munhoz LS; Larwood D; Martinez M; Stevens DA; Xavier MO
Med Mycol; 2021 Apr; 59(4):345-349. PubMed ID: 32634218
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and molecular characterisation of Sporothrix globosa of diverse origin from India.
Rudramurthy SM; Shankarnarayan SA; Hemashetter BM; Verma S; Chauhan S; Nath R; Savio J; Capoor M; Kaur H; Ghosh AK; Chakrabarti A
Braz J Microbiol; 2021 Mar; 52(1):91-100. PubMed ID: 32734470
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and antifungal susceptibility of Sporothrix species in Jiangxi, central China.
Li J; Zhan P; Jiang Q; Gao Y; Jin Y; Zhang L; Luo Y; Fan X; Sun J; de Hoog S
Med Mycol; 2019 Nov; 57(8):954-961. PubMed ID: 30657948
[TBL] [Abstract][Full Text] [Related]
13. Molecular identification and phenotypic characterisation of
Nath R; Lahon P; Timung L
Indian J Med Microbiol; 2017; 35(2):269-273. PubMed ID: 28681818
[TBL] [Abstract][Full Text] [Related]
14. In vitro antifungal susceptibility of Sporothrix globosa isolates from Jilin Province, northeastern China: comparison of yeast and mycelial phases.
Song Y; Li S; Shi Y; Zhao L; Cui Y; Yao L; Zhen Y; Chen R; Cui Y
Braz J Microbiol; 2021 Mar; 52(1):81-90. PubMed ID: 32557246
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of Sporothrix brasiliensis isolates to amphotericin B, azoles, and terbinafine.
Borba-Santos LP; Rodrigues AM; Gagini TB; Fernandes GF; Castro R; de Camargo ZP; Nucci M; Lopes-Bezerra LM; Ishida K; Rozental S
Med Mycol; 2015 Feb; 53(2):178-88. PubMed ID: 25394542
[TBL] [Abstract][Full Text] [Related]
16. Molecular identification of Sporothrix clinical isolates in China.
Liu TT; Zhang K; Zhou X
J Zhejiang Univ Sci B; 2014 Jan; 15(1):100-8. PubMed ID: 24390750
[TBL] [Abstract][Full Text] [Related]
17. A population genetics analysis in clinical isolates of Sporothrix schenckii based on calmodulin and calcium/calmodulin-dependent kinase partial gene sequences.
Rangel-Gamboa L; Martinez-Hernandez F; Maravilla P; Flisser A
Mycoses; 2018 Jun; 61(6):383-392. PubMed ID: 29394517
[TBL] [Abstract][Full Text] [Related]
18. Influence of iron on growth and on susceptibility to itraconazole in Sporothrix spp.
da Silva Hellwig AH; Pagani DM; Rios IDS; Ribeiro AC; Zanette RA; Scroferneker ML
Med Mycol; 2021 Apr; 59(4):400-403. PubMed ID: 33305309
[TBL] [Abstract][Full Text] [Related]
19. [In vitro susceptibility of isolates of Sporothrix schenckii to terbinafine and itraconazole].
Meinerz AR; Nascente Pda S; Schuch LF; Cleff MB; Santin R; Brum Cda S; Nobre Mde O; Meireles MC; Mello JR
Rev Soc Bras Med Trop; 2007; 40(1):60-2. PubMed ID: 17486256
[TBL] [Abstract][Full Text] [Related]
20. Genetic diversity and antifungal susceptibility profiles in causative agents of sporotrichosis.
Rodrigues AM; de Hoog GS; de Cássia Pires D; Brihante RS; Sidrim JJ; Gadelha MF; Colombo AL; de Camargo ZP
BMC Infect Dis; 2014 Apr; 14():219. PubMed ID: 24755107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
